<DOC>
	<DOCNO>NCT03094494</DOCNO>
	<brief_summary>An observational two-center case-control study explore clinical impact double-carbapenem use population critically il patient severe carbapenem-resistant Klebsiella pneumoniae infection</brief_summary>
	<brief_title>Double Carbapenem Rescue Strategy Treatment Carbapenemase-Producing Klebsiella Pneumoniae Infections</brief_title>
	<detailed_description />
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Klebsiella Infections</mesh_term>
	<criteria>1. age ≥ 18 year ; 2 . ICU admission November 2012 December 2015 ; 3. document CRKp invasive infection ; 4. target antibiotic therapy last ≥ 72 hour Exclusion Criteria 1 . Klebsiella infection , susceptible carbapenems 2 . Duration antimicrobial therapy le 72 hour 3 . Data completely available electronically medical chart</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>